615 related articles for article (PubMed ID: 17254637)
1. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
2. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
3. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
4. Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees.
Hankin CS; Koran L; Sheehan DV; Hollander E; Culpepper L; Black DW; Knispel J; Dunn J; Dougherty DD; Bronstone A; Wang Z
Ann Clin Psychiatry; 2011 Nov; 23(4):285-96. PubMed ID: 22073386
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
6. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
[TBL] [Abstract][Full Text] [Related]
7. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
9. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
Barsky AJ; Orav EJ; Bates DW
Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768
[TBL] [Abstract][Full Text] [Related]
10. The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.
Zhu B; Zhao Z; Ye W; Marciniak MD; Swindle R
J Nerv Ment Dis; 2009 Feb; 197(2):136-9. PubMed ID: 19214050
[TBL] [Abstract][Full Text] [Related]
11. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
[TBL] [Abstract][Full Text] [Related]
12. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
Zámbori J; Szádóczky E; Rózsa S; Füredi J
J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
[TBL] [Abstract][Full Text] [Related]
13. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
14. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
17. Patterns of mental health utilization and costs among children in a privately insured population.
Leslie DL; Rosenheck RA; Horwitz SM
Health Serv Res; 2001 Apr; 36(1 Pt 1):113-27. PubMed ID: 11324739
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
19. In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.
Gonzalez-Pinto AM; Dardennes R; de Zélicourt M; López P; Oliveros RG; Vieta E; Barbeito S; Echevarria E; Fagnani F
J Affect Disord; 2010 Feb; 121(1-2):152-5. PubMed ID: 19482360
[TBL] [Abstract][Full Text] [Related]
20. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]